Author

K. Piwocka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 3 Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Research Focus:cell type annotation· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:differential expression· 2 Assay:proteomics· 2

Frequent Co-Authors

M. Brewinska-Olchowik· 4 shared M. Miaczynska· 3 shared A. Kominek· 2 shared K. Jastrzebski· 2 shared L. Turos-Korgul· 2 shared A. Klejman· 1 shared A. Poswiata· 1 shared A. Szumera-Cieckiewicz· 1 shared

Activity by Year

2020-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCell Biology

M. Brewinska-Olchowik

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

High-throughput formulation of reproducible 3D cancer microenvironments for drug testing in myelogenous leukemia

M. Rudzinska-Radecka, L. Turos-Korgul, D. Mukherjee, P. Podszywalow-Bartnicka, K. Piwocka, J. Guzowski

This paper develops a high-throughput microfluidic system to generate reproducible 3D leukemia microenvironments for drug testing, showing that stroma-leukemia interactions protect cells from drug-induced cytotoxicity.

bioRxiv · Jan 10, 2024 · PreprintCancer Biology

Targeting Integrated Stress Response by ISRIB combined with imatinib attenuates STAT5 signaling and eradicates therapy-resistant Chronic Myeloid Leukemia cells

W. Dudka, G. Hoser, S. S. Mondal, L. Turos-Korgul, J. Swatler, M. Kusio-Kobiałka, M. Wolczyk, A. Klejman, M. Brewinska-Olchowik, A. Kominek, M. Wiech, M. M. Machnicki, I. Seferynska, T. Stoklosa, K. Piwocka

This study shows that combining ISRIB with imatinib reduces STAT5 signaling and eliminates imatinib-resistant CML cells by altering transcriptomic profiles.

bioRxiv · May 5, 2021 · PreprintCancer Biology

Concurrent depletion of Vps37 proteins evokes ESCRT-I destabilization and profound cellular stress responses

K. Kolmus, P. Erdenebat, B. Stewig, E. Szymanska, K. Goryca, A. Szumera-Cieckiewicz, E. Dereziska-Wolek, M. Brewinska-Olchowik, K. Piwocka, M. Prochorec-Sobieszek, M. Mikula, M. Miaczynska

The paper shows that depletion of Vps37 proteins destabilizes ESCRT-I, leading to cell growth inhibition and sterile inflammation in colorectal cancer.

bioRxiv · Jul 2, 2020Cell Biology

Splicing variation of BMP2K balances endocytosis, COPII trafficking and autophagy in erythroid cells

J. Cendrowski, M. Kaczmarek, K. Kuzmicz-Kowalska, M. Mazur, K. Jastrzebski, M. Brewinska-Olchowik, A. Kominek, K. Piwocka, M. Miaczynska

The paper identifies splicing variants of BMP2K that regulate erythroid differentiation by modulating COPII trafficking and autophagy through interactions with SEC16A.

bioRxiv · May 5, 2020 · PreprintCell Biology

GAS6-AXL signaling triggers actin remodeling and macropinocytosis that drive cancer cell invasion

D. Zdzalik-Bielecka, A. Poswiata, K. Kozik, K. Jastrzebski, K. O. Schink, M. Brewinska-Olchowik, K. Piwocka, H. Stenmark, M. Miaczynska

This study identifies GAS6-AXL signaling as a driver of cancer cell invasion through actin remodeling and macropinocytosis in glioblastoma cells under glutamine-deprived conditions.

bioRxiv · Mar 15, 2020 · PreprintCell Biology